	Intratumoral and Peritumoral Features for Predicting Microvascular Invasion in Hepatocellular Carcinoma: Systematic Review and Meta-Analysis. J Vis Exp Zhao B, Yu Y, Yang Y, Wang L, Li J. PMID: 42801297 [PubMed - indexed for MEDLINE]
	Advances in Drug Delivery Systems for Breast Cancer: From Microenvironment Barriers and Smart Carriers to Clinical Translation Strategies. Drug Des Devel Ther Liang G, Zhu C, Sun H, Ji Y, Jiang H. PMID: 42801248 [PubMed - indexed for MEDLINE]
	Current evidence across the treatment spectrum of adrenocortical carcinoma: a comprehensive scoping review. Endocr Oncol González-Clavijo AM, Fierro-Maya LF, Ballen DF, González-Devia D, Cuéllar-Cuéllar AA, García-Mora M, González-Ramírez DM, Tapiero-García M, Román-González A, Cabrera M, Sánchez-Castillo JO, Correa-Giraldo S, Builes-Montaño CE. PMID: 42801238 [PubMed]
	Gut Microbiota in Hepatocellular Carcinoma: Etiology-Specific Evidence, Mechanisms, and Translational Challenges. J Hepatocell Carcinoma Guan X. PMID: 42801214 [PubMed]
	A Hypoxia Associated STC2 High Endothelial Subpopulation is Linked to Lipid Metabolic Reprogramming, Pathological Angiogenesis, and Immune Remodeling in Head and Neck Squamous Cell Carcinoma. Int J Gen Med Chen K, Qin L, Liu Z, Zhu J, Li J, Qiu T, Xu S, Ying K, Zhu L, Wang F, Sun M. PMID: 42801171 [PubMed]
	Plasma circulating tumor deoxyribonucleic acid methylation enables noninvasive disease stratification beyond prostate-specific antigen in prostate cancer. Prostate Int Kim DW, Jung MH, Cho H, Cha J, Han KH, Choi JH, Park M, Park SH, Oh CK, Lee ST, Kim YJ, Chung JS. PMID: 42801146 [PubMed]
	Patients with high-risk features on active surveillance for prostate cancer. Prostate Int Goodman S, Dua Y, Pan HYC, Perera S, Sathianathen N, Perera M, Murphy D, Lawrentschuk N. PMID: 42801144 [PubMed]
	Comparison of Remimazolam and Propofol for Anesthesia Management in Liver Cancer Patients Undergoing Percutaneous Radiofrequency Ablation: A Randomized Controlled Trial. Drug Des Devel Ther Jiang P, Deng M, Wang Q, Feng Y, Wang D, Chen X. PMID: 42801141 [PubMed - indexed for MEDLINE]
	Efficacy of Lenvatinib versus Bevacizumab in Triple Therapy with Immune Checkpoint Inhibitors and Interventional Therapy for Hepatocellular Carcinoma with Macrovascular Invasion: A Multi-Center Real-World Retrospective Study. J Hepatocell Carcinoma Zhang J, Liu Y, Ding Y, Deng Z, Jiang B, Gao B, Hu S, Sun J, Yang X, Zhang H, Li B. PMID: 42801119 [PubMed]
	Diagnostic and Therapeutic Perspectives on Parotid Mammary Analog Secretory Carcinoma: Two Case Reports and Literature Review. Case Rep Otolaryngol Ferragina F, Barca I, Tarallo G, Sottile AR, Ioppolo MG, Cristofaro MG. PMID: 42801116 [PubMed]
	Erratum: Preclinical study of using multiphoton microscopy to diagnose liver cancer and differentiate benign and malignant liver lesions (Erratum). J Biomed Opt Yan J, Zhuo S, Chen G, Wu X, Zhou D, Xie S, Jiang J, Ying M, Jia F, Chen J, Zhou J. PMID: 42801093 [PubMed - in process]
	A cfDNA-based DNA methylation classifier for distinguishing prostate cancer from benign prostatic hyperplasia. Prostate Int Lee JH, Oh HJ, Koo HJ, Kim MY, Kim CS, Lim B, Lee JY, Park WY. PMID: 42801083 [PubMed]
	Nanosystem-Mediated Intercellular Crosstalk Modulation in the Tumor Microenvironment for Enhanced Cancer Immunotherapy. Drug Des Devel Ther Zheng X, Xie Y, Wang Q, Yao T, He Y, Wang Y, Lin X, Li M. PMID: 42801077 [PubMed - indexed for MEDLINE]
	Prediction of breast cancer metastasis based on Tri-training using Dempster-Shafer theory. Biomed Eng Lett Yang J, Huang Y, Lu Y, Zhang J, Shen Y, Fu X. PMID: 42800962 [PubMed]
	Multimodal transformers predict cancer therapy response from tumor mechanics. Array (N Y) Georgiou S, Stylianopoulos T, Voutouri C. PMID: 42800937 [PubMed]
	Multicentre evaluation of artificial intelligence risk classification for detection of clinically significant prostate cancer on biparametric MRI. Eur Radiol Guenzel K, Poirot MG, van Loon A, Messina E, Pecoraro M, Panebianco V, Princenthal R, Giganti F. PMID: 42800842 [PubMed - as supplied by publisher]
	A plasma derived hypoxia signature predicts benefit from hypoxia-modifying radiotherapy and reveals dynamic humoral immune modulation in bladder cancer. Br J Cancer Guerrero Quiles C, Abumanhal-Masarweh H, G Abalos J, Lodhi T, Sanchez-Martinez D, Reeves K, James ND, Hall E, Huddart RA, Porta N, Hoskin P, Biolatti LV, Hadjidemetriou M, West CM, Choudhury A. PMID: 42800813 [PubMed - as supplied by publisher]
	Reply to Roberto M. Scarpa's Letter to the Editor re: Paolo Gontero, Richard Perry, Daisy Bridge, et al. Unmet Treatment Need and Challenges Associated with Comparative Evidence Generation in BCG-unresponsive Non-muscle-invasive Bladder Cancer: An Expert Consensus. Eur Urol Oncol 2026;9(3):652-9. Eur Urol Oncol Gontero P, Babjuk M. PMID: 42800742 [PubMed - as supplied by publisher]
	Comment of 'Subsequent primary cancer incidence in cervical cancer survivors: insights from a comprehensive cohort study utilizing combined Japanese population-based cancer registries'. J Gynecol Oncol Ön S. PMID: 42800707 [PubMed - as supplied by publisher]
	Guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer: 2025 edition by the Japan Society of Gynecologic Oncology. J Gynecol Oncol Shoji T, Baba T, Kobayashi Y, Tokunaga H, Nagase S, Abiko K, Shimada M, Takano M, Yamagami W, Tanabe H, Nakashima A, Kajiyama H, Asai-Sato M, Takekuma M, Takehara K, Tabata T, Noda SE, Harano K, Hirashima Y, Yunokawa M, Morisada T, Okamoto A. PMID: 42800706 [PubMed - as supplied by publisher]

Articles 1 - 20 / 1976130

Page 1 of 98807



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy